Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Added in October 2025
13 October
NEW - 14-15 October CMDh agenda
Added in…
modified 13/10/2025
Meeting 14-15 October 2025: AgendaMeeting 16-18 September 2025: AgendaMeeting…
modified 13/10/2025
National recommendations for requests to act as RMS (March 2024)
modified 06/10/2025
Havrix (hepatitis A virus strain HM175 (RIT4380), inactivated)End of procedure:…
modified 26/09/2025
Pheniramine maleate, naphazoline hydrochlorideEnd of procedure: 11/08/2025Date…
added 25/09/2025
Overview of timetables
modified 25/09/2025
Referral decisions and new product information changes can be found on:
the…
modified 25/09/2025
RMS Validation Checklist for human medicinal products in DCP (September 2025)…
modified 25/09/2025
Request for RMS in a Decentralised Procedure, medicinal products for human use
modified 25/09/2025
2025, Q1-Q2 - Statistics for New Applications (MRP/DCP), Variations, Referrals…
modified 25/09/2025